StoxRadar is free — only 218 spots left in beta.

SPY$777.22-0.24%QQQ$757.73-0.25%DIA$511.02-0.69%IWM$277.70-1.29%AAPL$336.67+0.91%MSFT$529.76+0.09%NVDA$237.47-0.74%AMZN$259.92+1.42%GOOGL$350.50+0.81%META$721.31-2.38%TSLA$377.81-0.75%JPM$329.58-0.51%GLD$375.88-1.67%BTC$36.88-2.54%IBIT$47.21-2.64%SPY$777.22-0.24%QQQ$757.73-0.25%DIA$511.02-0.69%IWM$277.70-1.29%AAPL$336.67+0.91%MSFT$529.76+0.09%NVDA$237.47-0.74%AMZN$259.92+1.42%GOOGL$350.50+0.81%META$721.31-2.38%TSLA$377.81-0.75%JPM$329.58-0.51%GLD$375.88-1.67%BTC$36.88-2.54%IBIT$47.21-2.64%

StoxRadar is free.

NXTS

NXTS

NASDAQ

Nexentis Technologies Inc.

Basic Materials · Agricultural Inputs

$1.08
-0.31-22.30%
Day Range: $0.94 – $1.19
Market Cap
$61,123
Volume
18.36M
52W High
$32.90
52W Low
$0.94
P/E Ratio
-0.06
EPS (TTM)
$-19.64
Div Yield
—
Beta
1.86

Price History

08-2609-0309-1409-2209-30$1$1.25$1.5$1.75$2

Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational chemistry platform; and novel in-vitro screening platforms; and advanced 3D NSCLC tumor spheroid systems.The company was formerly known as N2OFF, Inc. and changed its name to Nexentis Technologies Inc. in February 2026. Nexentis Technologies Inc. was incorporated in 2009 and is headquartered in Ness Ziona, Israel.

CEO
David Palach
Employees
8
Headquarters
Ness Ziona, IL
IPO Date
2026-02-26
BETA

Get started for full access.